Home | Welcome to Contract Pharma   
Last Updated Wednesday, October 22 2014
Print

Breaking News

Related Searches:
February 2, 2011
Without Tamiflu revenues, pharma dipped.  Read More »
February 2, 2011
Modern insulins drive growth for NN  Read More »
February 2, 2011
Acquisitions help with revenue growth  Read More »
February 2, 2011
ICH compliance enhances stability offerings  Read More »
February 1, 2011
Greenstreet to head medicines development for Specialty Care  Read More »
February 1, 2011
Wyeth products boost revenues, but a decline is predicted  Read More »
February 1, 2011
Tysabri, Avonex revenues continue to climb  Read More »
February 1, 2011
Henderson named VP, general counsel and secretary  Read More »
February 1, 2011
New name focuses on biopharma services  Read More »
January 31, 2011
Brussels site to formulate, fill, package interferon product for Phase III, potential commercial supply  Read More »
January 31, 2011
Expands preclinical pipeline and translational base with $111 million acquisition.  Read More »
January 31, 2011
Pfizer, OncoMed advance HuCAL programs  Read More »
January 31, 2011
Due diligence phase begins in slow-motion acquisition  Read More »
January 31, 2011
New CSO comes from Lilly biomanufacturing  Read More »
January 28, 2011
PharmaNet Development Group, Inc. and Anapharm Europe, S.L., have ended their bioanalytical services joint venture as of December 22, 2010.   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On